OncoSec Medical Incorporated announced that on October 1, 2022, James M. DeMesa, M.D. notified the Company of his resignation from the Company's Board of Directors, effective October 1, 2022. Concurrently with such resignation, Dr. DeMesa ceased to serve as Chair of each of the Audit and Nominating and Corporate Governance Committees of the Board and ceased to serve as a member of the Compensation Committee of the Board.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | -99.67% | -99.67% | 0.00% |
2023 | Motion for Asset Sale Approved for OncoSec Medical Incorporated | CI |
2023 | Motion for Asset Sale Filed by OncoSec Medical Incorporated | CI |
1st Jan change | Capi. | |
---|---|---|
0.00% | 5 | |
+33.63% | 50.93B | |
-0.09% | 42.12B | |
+49.62% | 42.05B | |
-4.96% | 29.18B | |
+11.18% | 26.02B | |
-21.95% | 18.9B | |
+8.61% | 13.21B | |
+24.73% | 12.17B | |
+28.31% | 12.16B |
- Stock Market
- Equities
- ONCSQ Stock
- News OncoSec Medical Incorporated
- Oncosec Medical Incorporated Announces Retirement of James M. Demesa from the Board of Directors